Send Press Release To Your Friends

PR Title:	Cmed Technology adds more capabilities to its encapsia platform and reports increased demand for use in decentralized trials (DCT)
PR Summary:	Innovative technology for clinical trials is now, more than ever, necessary to deliver decentralized trials (DCT) and enable design of hybrid protocols that support trial continuity and patient-centricity.

	Basic Information
	Your Name* Your Email* Friend's Name Friend's Email 1* 2   3   Your Message